Choice of chemotherapy regimen for early HER2-positive breast cancer in elderly patients

Chin Clin Oncol. 2018 Feb;7(1):4. doi: 10.21037/cco.2017.11.01. Epub 2017 Dec 14.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / enzymology*
  • Breast Neoplasms / pathology
  • Female
  • Humans
  • Middle Aged
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Receptor, ErbB-2 / metabolism*

Substances

  • ERBB2 protein, human
  • Receptor, ErbB-2